TOVX
Theriva Biologics, Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-01-05 | Kraws Jeffrey J |
Co-President |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
75,000 |
| 2026-01-05 | Wolf Jeffrey Alan |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
75,000 |
| 2026-01-05 | MONAHAN JOHN J |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
75,000 |
| 2026-01-05 | SHALLCROSS STEVEN A |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 36 months. |
Stock Options (right to buy)
|
475,000 |
| 2025-04-29 | MONAHAN JOHN J |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
25,000 |
| 2025-04-29 | Kraws Jeffrey J |
Co-President |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
25,000 |
| 2025-04-29 | Wolf Jeffrey Alan |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
25,000 |
| 2025-04-29 | SHALLCROSS STEVEN A |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 36 months. |
Stock Options (right to buy)
|
190,000 |
| 2023-12-14 | Wolf Jeffrey Alan |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
110,000 |
| 2023-12-14 | Kraws Jeffrey J |
Co-President |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
110,000 |
| 2023-12-14 | SHALLCROSS STEVEN A |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 36 months. |
Stock Options (right to buy)
|
700,000 |
| 2023-12-14 | MONAHAN JOHN J |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
110,000 |
| 2023-06-07 | SHALLCROSS STEVEN A |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.6699 through $0.699, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
14,000 |
| 2023-06-06 | SHALLCROSS STEVEN A |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.6015 through $0.6659, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
26,000 |
| 2023-02-10 | SHALLCROSS STEVEN A |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.02 through $1.05, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
25,000 |
| 2023-02-02 | SHALLCROSS STEVEN A |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.9349 through $0.9499, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
25,000 |
| 2023-01-25 | SHALLCROSS STEVEN A |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.860 through $0.875, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
Common Stock
|
25,000 |
| 2023-01-20 | SHALLCROSS STEVEN A |
Director |
Buy↑
|
Common Stock
|
25,000 |
| 2022-12-29 | SHALLCROSS STEVEN A |
Director |
Buy↑
|
Common Stock
|
100,000 |
| 2022-12-15 | MONAHAN JOHN J |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
100,000 |
| 2022-12-15 | SHALLCROSS STEVEN A |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 36 months. |
Stock Options (right to buy)
|
475,000 |
| 2022-12-15 | Kraws Jeffrey J |
Co-President |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
100,000 |
| 2022-12-15 | Tufaro Francis |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 36 months. |
Stock Options (right to buy)
|
100,000 |
| 2022-12-15 | Wolf Jeffrey Alan |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
100,000 |
| 2021-12-23 | MONAHAN JOHN J |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
200,000 |
| 2021-12-23 | Kraws Jeffrey J |
Co-President |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
200,000 |
| 2021-12-23 | Wolf Jeffrey Alan |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 12 months. |
Stock Options (right to buy)
|
200,000 |
| 2021-12-23 | SHALLCROSS STEVEN A |
Director |
Award↑
Filing footnotes — Stock Options (right to buy) (Direct)
These stock options vest pro rata on a monthly basis over 36 months. |
Stock Options (right to buy)
|
650,000 |
| 2021-05-10 | SHALLCROSS STEVEN A |
Director |
Buy↑
|
Common Stock
|
50,000 |
| 2020-12-30 | Kraws Jeffrey J |
Co-President |
Award↑
Filing footnotes — Stock Options (Direct)
These stock options will vest pro rata on a monthly basis over 12 months. |
Stock Options
|
150,000 |
| 2020-12-30 | Wolf Jeffrey Alan |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Options (Direct)
These stock options will vest pro rata on a monthly basis over 12 months. |
Stock Options
|
150,000 |
| 2020-12-30 | SHALLCROSS STEVEN A |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
These stock options will vest pro rata on a monthly basis over 36 months. |
Stock Options
|
450,000 |
| 2020-12-30 | MONAHAN JOHN J |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
These stock options will vest pro rata on a monthly basis over 12 months. |
Stock Options
|
150,000 |
| 2020-11-11 | Tarriff Scott |
Director |
Other↑
|
No Securities Owned
|
0 |